InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Wagenheim Philip, 董事. Director active across 2 companies, notably Immunome Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €853k. History available since 24 May 2021. The latest transaction was filed on 20 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Philip Wagenheim is a Director at Immunome Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Immunome.